Literature DB >> 17023120

Pathogenesis of septal fibrosis of the liver. (An experimental study with a new model.).

Márcia Maria De Souza1, Miguel Tolentino, Bárbara C A Assis, Ana Cristina De Oliveira Gonzalez, Tânia Maria Correia Silva, Zilton A Andrade.   

Abstract

Septal fibrosis is an important, frequent, and non-specific type of fibrosis associated with chronic liver diseases, but its pathogenesis is still poorly understood. An interesting model of septal fibrosis occurs in rats infected with the nematode Capillaria hepatica. This model was used to investigate the pathogenesis, site of origin, structure, and cell-types of septal fibrosis. Forty young adult Wistar rats were inoculated with 800 embryonated eggs of C. hepatica. Daily liver samples were obtained from the 20th to the 39th day after inoculation to cover the critical period when septal fibrosis usually starts. Routine histology, electron microscopy, immunohistochemistry, and indirect immunofluorescence were applied to the study of liver sections. Septal blood vessels were demonstrated by India ink perfusion of the portal vein system. Prominent angiogenesis was observed to precede collagen deposition. Besides angiogenesis and mesenchymal-cell mobilization, septal fibrosis was seen to originate from portal spaces and to course through acinar zone I in between sinusoids, inducing no alterations in them, with no evident participation of stellate hepatic cells. Septal fibrosis appeared as an adaptative type of response of the liver to chronic injury, which resulted in a new structure that is normal to other species and creates accessory vessels that drain portal blood into hepatic sinusoids.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17023120     DOI: 10.1016/j.prp.2006.07.004

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  3 in total

1.  Histopathological features and prevalence of Capillaria hepatica infection in Rattus spp. in Philippine Mount Makiling forest reserve and its adjacent areas.

Authors:  Maria Henrietta D P Quilla; Vachel Gay V Paller
Journal:  J Parasit Dis       Date:  2020-01-02

2.  Bevacizumab attenuates hepatic fibrosis in rats by inhibiting activation of hepatic stellate cells.

Authors:  Yangqing Huang; Helin Feng; Tong Kan; Bin Huang; Minfeng Zhang; Yesheng Li; Changying Shi; Mengchao Wu; Yunquan Luo; Jiamei Yang; Feng Xu
Journal:  PLoS One       Date:  2013-08-30       Impact factor: 3.240

3.  An algorithm that predicts the viability and the yield of human hepatocytes isolated from remnant liver pieces obtained from liver resections.

Authors:  Serene M L Lee; Celine Schelcher; Rüdiger P Laubender; Natalja Fröse; Reinhard M K Thasler; Tobias S Schiergens; Ulrich Mansmann; Wolfgang E Thasler
Journal:  PLoS One       Date:  2014-10-14       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.